ClinicalTrials.govpublic full text
Olaparib for PAH: a Pilot Study
pulmonary arterial hypertension, pah, poly (adp-ribose) polymerases inhibition, parp-1 inhibition, dna damage, early-phase clinical trial pilot study, olaparib, safety and efficacy, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846331
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.